Fusion Antibodies
Fusion Antibodies plc is a contract research organization based in Belfast, United Kingdom, specializing in the research, development, and manufacture of recombinant proteins and antibodies, particularly for cancer and infectious diseases. The company provides a comprehensive suite of services, including monoclonal antibody discovery and development, antibody engineering, humanization, affinity maturation, and antibody reformatting. Additionally, its offerings encompass antibody sequencing, custom expression and purification of recombinant proteins, transient protein expression, and cell line development. Fusion Antibodies operates on a fee-for-service basis, tailoring its services to meet the specific needs of pharmaceuticals, biotechnology, and diagnostic companies. Established in 2000, the company has built strong partnerships globally, enhancing its ability to deliver high-quality solutions. Its expertise in producing fully humanized monoclonal antibodies is critical for advancing drug development to clinical stages.
Selexis SA
Acquisition in 2012
Selexis SA is a life sciences company based in Plan-les-Ouates, Switzerland, specializing in mammalian cell-line generation technologies aimed at advancing the development of new therapies into life-saving medicines. Established in 2001, the company utilizes its proprietary Selexis SUREtechnology Platform to facilitate the discovery, development, and manufacture of recombinant proteins. Selexis offers a range of services including cell-line development, lead identification, and genomic characterization, which are essential for bioproduction, preclinical production, and diagnostics. The company serves biotechnology and pharmaceutical firms globally, providing critical support in the drug discovery process and the scale-up to manufacturing of therapeutic proteins. As of June 2017, Selexis operates as a subsidiary of KBI Biopharma Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.